Published in Vaccine Weekly, August 9th, 2006
However, this particular vaccine is not approved for use in the United States, and while it may boost immunity, no randomized controlled studies so far have proven its actual clinical effectiveness. Such vaccines are already widely used in Great Britain, Canada and Spain.
"The studies in our review showed that MCC vaccine was highly immunogenic in infants after two and three doses, in toddlers after one and two doses, and in older age groups after one dose," said lead researcher Dr. Lucieni...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly